在贝叶斯逻辑回归模型中利用药物动力学参数作为共变量,以优化早期瘤学试验中的剂量选择
Xin Wei1, Xiaosong Li1, Ziyan Guo1
1Global Biometrics and Data Science, Bristol Myers Squibb, Madison, New Jersey, USA.
Journal of biopharmaceutical statistics
|July 19, 2024
概括
优化早期瘤学药物开发需要平衡安全性和有效性. 这项研究使用双变贝叶斯逻辑回归 (BLRM) 与药理动力学 (PK) 数据来增强剂量选择,改善了晚期试验最佳剂量的识别.
科学领域:
- 瘤学 药物开发 药物开发
- 临床试验设计 临床试验设计
- 生物统计学 生物统计学
背景情况:
- 早期瘤学试验对于成功开发药物至关重要.
- 传统的剂量确定方法,如3+3,可能无法充分平衡安全性和有效性.
- 双变贝叶斯逻辑回归 (BLRM) 提高了基于剂量限制毒性 (DLT) 的剂量选择精度.
研究的目的:
- 为了解决在I期瘤学试验中优化剂量选择的挑战.
- 为了研究药物动力学 (PK) 变异性对剂量选择的影响.
- 建议在升级和扩展阶段改进剂量选择的方法.
主要方法:
- 利用I期临床试验数据集来证明挑战.
- 采用模拟研究来评估BLRM与PK共变量.
- 开发了基于模型和基于规则的方法,用于扩展队列中患者级剂量修改.
主要成果:
- 将BLRM与剂量独立的PK参数作为共变量,提高了基于DLT率识别最佳剂量水平的准确性.
- 基于扩展队列中的PK参数的患者水平剂量修改策略建议.
- 模拟表明,更有可能推进可控毒性和疗效的剂量.
结论:
- 将PK数据集成到BLRM模型中可以提高早期瘤学试验中剂量选择的准确性.
- 在扩张队列中针对患者的剂量调整可以提高成功晚期发育的概率.
- 这种方法为优化在早期瘤药物开发阶段的剂量选择提供了更强大的策略.
相关概念视频
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Nonlinear Pharmacokinetics: Overview
337
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
337
Pharmacokinetic Models: Comparison and Selection Criterion
66
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
66
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
67
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
67
Pharmacokinetic Models: Overview
643
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
643
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
56
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
56


